RecallDepth
Class II Terminated

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
August 23, 2022
Posted
September 7, 2022
Recall Number
D-1473-2022
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 3007830, 3007746, 3007829, Exp. Date 10/2024

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls